Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients
about
sameAs
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.MT1 and MT2 Melatonin Receptors: A Therapeutic PerspectiveMelatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brainEndogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle.Melatonin and anesthesia: a clinical perspective.Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growthThe pattern of melatonin receptor expression in the brain may influence antidepressant treatmentMelatonin Therapy in Patients with Alzheimer's Disease.Role of melatonin in Alzheimer-like neurodegeneration.Are G protein-coupled receptor heterodimers of physiological relevance?--Focus on melatonin receptors.Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?Melatonin in Alzheimer's diseaseChronic ramelteon treatment in a mouse model of Alzheimer's disease.Expression and putative functions of melatonin receptors in malignant cells and tissues.Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.Update on melatonin receptors: IUPHAR Review 20.Mechanisms of Melatonin in Alleviating Alzheimer's Disease.Melatonin receptors: distribution in mammalian brain and their respective putative functions.Neuroanatomical distribution of the orphan GPR50 receptor in adult sheep and rodent brains.Detection of the human GPR50 orphan seven transmembrane protein by polyclonal antibodies mapping different epitopes.Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain.Drug- and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1) and MT(2) receptor mRNA in the mouse brain.Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors.Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle.A multicomponent nonpharmacological intervention improves activity rhythms among nursing home residents with disrupted sleep/wake patterns.Prophylactic Melatonin Attenuates Isoflurane-Induced Cognitive Impairment in Aged Rats through Hippocampal Melatonin Receptor 2 - cAMP Response Element Binding Signalling.Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer's type dementia: a case series.Food-Induced Reinforcement is Abrogated by the Genetic Deletion of the MT1 or MT2 Melatonin Receptor in C3H/HeN Mice.Melatonin attenuates isoflurane-induced acute memory impairments in aged rats.Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.Citalopram attenuates tau hyperphosphorylation and spatial memory deficit induced by social isolation rearing in middle-aged rats.Analysis of the daily changes of melatonin receptors in the rat liver.Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon.The combination of agomelatine and ritanserin exerts a synergistic interaction in passive avoidance task.Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties.Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.The presence and localization of melatonin receptors in the rat aorta.
P2860
Q24623433-D4360A0C-D0E3-4900-BCC5-3B307CCCFD5BQ28083929-5094F6F8-CA08-4DF1-837A-21C31E6237B0Q28574914-0B6D5E96-E46A-43C6-AD50-AF64E7C18872Q33897576-20C1B405-43F8-43A7-B55A-9AA073088B71Q34596664-6ACD36BD-C915-4B2E-9D05-9A6403B8D918Q35276597-BB0B20D8-71E8-471D-A418-737F946F0266Q35321923-28C90192-E1D0-4DD4-8D9F-0D427C54E743Q35945875-E2526144-08C7-4DF7-B27A-17B922750AFAQ36335048-515B9EE4-0454-4D4C-922D-A24D83B7712AQ36346522-5B439924-4591-425C-B137-6B879DAA1762Q36474528-B507A420-487E-4246-8A1B-2BD7C264BB3EQ36790172-B6BED731-7299-4F02-9774-3DFFFF5C782DQ37091982-29602E11-3124-4E94-804B-643553150259Q37412437-A470AE20-7252-4FC6-97E8-DBF66B80B22EQ38229317-1F64C764-9D2B-43EE-BEA8-E654ABB91348Q38243554-AF966A82-EB44-4152-82A7-0C33B1CA2888Q38858846-81FADBA0-190C-4B7B-925C-360B4C3DB731Q38868297-AC36BFBA-AEA9-45FF-A35E-0A5B5B5E5531Q39178920-2EA8A58D-F039-4A2D-9E53-EB9124145449Q39288514-FC6CD294-9A3A-449A-A75A-A8FF80F89097Q39627987-4BA5394C-6367-49C3-A384-9B45943E5C96Q40110671-96D30387-39CC-4B10-89A5-ED3DB81F3947Q40477472-DA3CCF0B-93DD-4D97-A4BB-EF209FEF7FEDQ41333290-A12E7A8E-A254-4ACE-B569-6F615986D073Q41891925-338F4089-53E6-4141-8F9D-E144F768D2A9Q41952507-0D3714D2-9514-4C5D-9150-EDA8DDFECB1AQ42491063-CE47BAAD-184E-48A6-914C-C087C4985486Q45945107-B450BA47-3EF0-4EDB-BB34-E91F4BF530F3Q47399558-D74D74B5-5109-4BC9-B442-C7E2C15C6CF2Q47770202-0DB6C115-2061-4B5C-B7B4-2B76A2FA9F90Q47837095-C1DD9A12-B9A9-410A-B806-4EA5AE272AFFQ48013655-B1F917A4-6363-45BC-B8BB-94C491563D6BQ48088836-F859B074-3DBB-4014-B147-FC68579C4C81Q48158214-D8743B78-9544-4430-B3A5-C0F0980B672AQ48315401-77D909CF-36DF-49ED-9F56-EA63FBD1B61BQ48431434-2F418D9E-ECB9-40AF-B1BD-0773A94A26B0Q50623837-EB01E2EE-00EF-434E-914C-2B2FB7F4A63EQ51592809-DCB217C6-86C7-4CD2-9A9E-9A69094B083EQ52994249-B915B93B-1929-4A9F-9BCB-130DB881C8F3Q54363570-D5FED186-549E-4E26-A3AB-D3BC046FA03B
P2860
Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Jahr 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2002)
@en
vedecký článok (publikovaný 2002-01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-01)
@nl
наукова стаття, опублікована в січні 2002
@uk
مقالة علمية (نشرت عام 2002)
@ar
name
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@ast
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@en
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@nl
type
label
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@ast
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@en
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@nl
prefLabel
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@ast
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@en
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@nl
P2093
P921
P1476
Increased melatonin 1a-recepto ...... f Alzheimer's disease patients
@en
P2093
Anna Wirz-Justice
Egemen Savaskan
Fides Meier
Franz Müller-Spahn
Gianfranco Olivieri
Lena Brydon
Ralf Jockers
Rivka Ravid
P356
10.1034/J.1600-079X.2002.00841.X
P407
P577
2002-01-01T00:00:00Z